Abstract
Sporotrichoid‐lymphocutaneous‐pattern is classically seen in sporotrichosis, though also present in other infections like atypical mycobacteriosis and leishmaniasis. Cutaneous atypical mycobacterial infection presents as localized lesions in immunocompetent and is widespread in immunosuppressed patients. Here, we present a case of sporotrichoid‐lymphocutaneous infection due to atypical mycobacteria, in a fish‐seller under immunosuppressants.
Keywords: atypical mycobacterium, lymphocutaneous pattern, Mycobacterium marinum, Sporotrichoid
1. INTRODUCTION
Most cases of nodular lymphangitis or sporotrichoid lesions are the result of infectious and noninfectious diseases. Sporotrichoid lymphocutaneous infections are characterized by suppurative inflammatory nodules along the lymphatic vessels. This is the classic feature of sporotrichosis though other infections such as nocardiosis, atypical mycobacteriosis, and leishmaniasis, can also present with this clinical pattern. 1 Mycobacterium marinum is an atypical mycobacterium found in both freshwater and saltwater. M. marinum infection is commonly referred to as “fish tank granuloma,” which commonly affects aquarium workers, swimmers, anglers, or marine enthusiasts. Infections typically present with subcutaneous nodules and lymphangitis. 2 Although diagnosis is confirmed by isolation and identification of the organism, however, in practice diagnosis remains largely presumptive based on clinic‐histological features and the response to treatment. 3 Here, we present a case of sporotrichoid lymphocutaneous infection in a female fish handler on immunosuppressive medications.
2. CASE REPORT
A 45‐year‐old female shopkeeper from the hilly district of Eastern Nepal was presented to our Dermatology outpatient department with erythematous painful nodules over the left hand, forearm, and arm along the radial border for 10 days and swelling of the left hand for 5 days. She had a history of pain over the left arm and forearm in the past 10 months for which she was treated with oral corticosteroids, methotrexate, and hydroxychloroquine from nearby health facilities and hospitals. She denied any history of trauma prior to the appearance of lesions.
On examination, there were six tender erythematous nodules with the local rise in temperature present along the radial border of the left hand, forearm, and arm with oedema of the left hand extending from proximal third of fingers to wrist joint (Figure 1).
FIGURE 1.

(A, B) Initial presentation with multiple erythematous nodules in sporotrichoid lymphocutaneous pattern in left hand and forearm
Investigations showed normal complete blood count, blood sugar, chest X‐ray, urine routine microscopy, and serum cortisol levels with positive CRP although the RA factor and serology (HIV, Hep B, Hep C) were negative. Liver transaminases (AST and ALT) were only mildly increased (1.6 times) and vitamin D level low (21.6). The wound swab culture was sterile, and the microfilaria test was negative. An incisional skin biopsy was done and sent for histopathological examination and tissue culture for both bacteria and fungus.
The diagnosis of sporotrichoid lymphocutaneous pattern secondary to infection (probably streptococcal infection or sporotrichosis or atypical mycobacteria) was made. She was started on oral antibiotics (cefixime and doxycycline), analgesics, chymosin, and other supporting medications.
On her follow‐up visit, there was persistent discharge from the nodules with mild tenderness. New lesions were appearing in a similar linear fashion along the ulnar border of the left hand and forearm. Later, her skin biopsy reports showed lymphohistiocytic collection admixed with neutrophils and activated macrophages forming epithelioid aggregate and ill‐defined granuloma with acid fast bacilli (AFB) stain positive for bacteria. However, the Slit skin smear for M. leprae and sputum for AFB were negative. Culture revealed no growth. Further inquiry into the patient's occupation revealed her occupation as a fish handler in her shop. On this background, a revised provisional diagnosis of sporotrichoid lymphocutaneous pattern secondary to atypical mycobacterial infection probably M. marinum was made and the patient was started on per oral tab Ethambutol 800 mg once daily and tab clarithromycin 500 mg twice daily along with cap Doxycycline 100 mg twice daily. After 2 months of treatment, the patient responded with complete resolution of cutaneous lesions with scarring and no new lesions appearance since the start of treatment (Figure 2). The treatment was continued for further 6 months. There was no recurrence with complete resolution of lesions at the end of 8 months which continued in the 1 month follow‐up after stoppage of treatment. The patient is still kept in regular follow‐up.
FIGURE 2.

Complete resolution of lesions at 6 months of Clarithromycin, ethambutol and doxycycline
3. DISCUSSION
A sporotrichoid pattern, or nodular lymphangitis, describes a distinctive clinical presentation in which inflammatory nodules spread linearly along the path of lymphatic drainage. It can be caused by infectious and noninfectious etiologies. Acute infection is generally caused by streptococcal or staphylococcal bacteria. Chronic infection is generally due to fungal (esp. Sporotrichosis), atypical mycobacteria, or Leishmaniasis. It is the classic manifestation of sporotrichosis caused by Sporothrix schenkii, but it can also result from cutaneous inoculation with Mycobacterium, Leishmania, or Nocardia species, as well as several other inflammatory and neoplastic conditions.
Nearly 80% of the Sporothrix schenkii affected patients present the lymphocutaneous form. 2 Similarly, Nontuberculous mycobacteria are an important cause of sporotrichoid lymphocutaneous infections with the most prominently associated species being M. marinum. 1 In a case series, about 25% of cases with M. marinum infection showed sporotrichoid pattern. 3 Up to 25% of patients with skin or soft‐tissue infections related to N. brasiliensis will develop sporotrichoid lesions. 1 In the Old World, sporotrichoid leishmaniasis has mainly been associated with L. major ZCL with incidence ranges from 1.7% to 22%. 4 Few cases of neoplasm in the sporotrichoid fashion have been reported like keratoacanthoma, epithelioid sarcoma, Langerhans cell histiocytosis, lymphoma, melanoma, peripheral nerve sheath tumor, and squamous cell carcinoma. 5
Characteristics of main differential diagnoses for nodular lymphangitis is given in Table 1.
TABLE 1.
Characteristics and clues to main differential diagnosis diagnoses of Nodular lymphangitis
| Agent | Risk factor | Incubation period | Primary lesion | Lymphadenitis | Systemic symptoms | Pathology/culture |
|---|---|---|---|---|---|---|
| Sporothrix schenckii | Gardening (roses), corn crop, soil contact, sphagnum moss, animal scratches (cats) or bites | 1 week–3 months | Painless ulcerated nodule | Occasional | No | Granulomatous infiltrate with asteroids bodies and elongated yeast/Culture (Sabouraud agar at 32°C |
| Mycobacterium marinum | Aquariums, fish‐handling (fresh and saltwater fish), swimming in oceans, lakes, pools | 1–6 weeks | Mildly tender, often ulcerated nodule, with scant seropurulent exudate | Occasional | No | Suppurative granulomas/Culture on Lowenstein–Jensen or Middlebrok agar at 30–32°C |
| Nocardia brasiliensis/N. asteroids | Soil exposure, botanicals, cat scratch | 3 days–6 weeks | Tender nodules commonly ulcerated with mild to abundant purulent drainage | Commo | Mild | Granulomas and sulfur granules, giant cells, abscess formation/Culture in most media |
| Leishmania brasiliensis | Residence in or travel to endemic areas | 2–24 weeks | Painless, well‐demarcated shallow ulcer with indurated borders | Occasional | No | Amastigotes within histiocytes/Culture on tissue biopsy or impression smears usually in Nicolle–Novy–Macneal medium or animals |
| Francisella tularensis | Hunting and other rural outdoor activities, transmitted through ticks, deer flies, wild mammals (rabbits, squirrels, voles), cats | 1–6 days | Painful ulcerated papule with suppuration | always | Moderate ‐severe | Granulomatous reaction, multinucleated giant cells, epithelioid cells, neutrophils with focal necrosis/Serology, culture isolation with safety hood |
| Staphylococcus aureus | 4–10 days | Nodular lesions, frequently abscessed, with drainage of purulent fluid | – | – | Botryomycotic grains/Culture on most media |
The diagnostic approach for infective nodular lymphangitis is shown in Figure 3.
FIGURE 3.

Diagnostic approach in nodular lymphangitis
In our present case, on the basis of clinicopathological correlation, we made a diagnosis of M. marinum infection which is a non‐tuberculous mycobacterium found in non‐chlorinated water, with worldwide prevalence. It is the most common atypical Mycobacterium that causes opportunistic infection in humans. 3 M. marinum is a non‐motile acid‐fast bacillus, that grows at 30–32°C (86–89.6°F). It grows best on Lowenstein–Jensen media. The clinical presentation varies depending upon the immune status of the individuals. The immunocompetent patients typically present with localized lesions as a solitary, red‐to‐violaceous plaque or nodule with an overlying crust or verrucous surface infection, whereas immunosuppressed patients may present with widespread cutaneous lesions as inflammatory nodules, pustules, ulcers, or abscesses, in a sporotrichosis type of distribution or widespread lesions or with signs of systemic infection. 3 Mycobacteria are notorious for not growing in culture even under the most ideal conditions. Recently, polymerase chain reaction (PCR) testing on swabs of ulcers or tissue biopsies is considered as the diagnostic test for atypical mycobacteria; this facility is not available freely. Therefore, if the history and physical examination suggest M. marinum infection, empiric treatment should be strongly considered even in the absence of biopsy or culture confirmation. 6
The mainstay of treatment in M. marinum infection is antimicrobial therapy. The effective antimicrobials include tetracyclines, fluoroquinolones, macrolides (e.g., clarithromycin), rifampicin, and sulfonamides (cotrimoxazole). However, because of rarity of disease, very few studies are available regarding efficacious treatment of M. marinum infection. The duration of therapy is also not well defined, but treatment of skin and soft‐tissue infections should be continued for 1–2 months after resolution of symptoms and lesions. Therefore, the treatment duration is typically 3–4 months, longer if deeper structures are involved. Some authors have suggested a minimum duration of 6 months. In some cases, a treatment duration of up to 2 years has been reported. Combination treatment with two active agents is preferred, although success has been obtained with single‐agent approach. Spontaneous resolution of M. marinum infection has been reported.
Aubry et al. 2 noted that in the past, M. marinum has been treated with tetracyclines, sulfamethoxazole and trimethoprim, rifampin plus ethambutol, clarithromycin, levofloxacin, and amikacin. Eighty‐seven percent of the patients in their study were cured after therapy that included clarithromycin, rifampin, or tetracyclines. There were also treatment failures with the same antibiotics. 2 Krooks et al. 7 reported that the patient initially responded completely to minocycline oral 100 mg twice daily for 12 weeks but after 1 month of discontinuation of minocycline, there was recurrence of lesion. Treatment with clarithromycin (500 mg twice a day) and ethambutol (15 mg/kg once a day) was started leading to the resolution of the lesions in 2 weeks. The treatment was then continued for two more months. 7 This demonstrates that longer duration of treatment is required to avoid recurrences in cases of M. marinum infections.
Similarly, Fleming and Keystone 8 reported a 52‐year‐old immunocompetent male with M. marinum infection in sporotrichoid pattern treated with doxycycline 100 mg orally twice daily for 3 months. The initial response was excellent but longer follow‐up was not done. 8
Our case is unique in that the patient might have exposure to the pathogen as she used to handle raw freshwater fish in her shop. The pathogen found in freshwater, that is, M. marinum might have inoculated into her skin via minor trauma in her skin unnoticed by the patient while handling the fish.
Though there is no strong evidence and guidelines regarding treatment of M. marinum infection. In available case reports, combination therapy had shown better response than the monotherapy. Also, in the immunosuppressed patients, there is chance of disseminated lesions with severe presentation requiring more than two drugs combination and, in such cases, treatment with only two drugs have shown relapse of disease on longer follow‐up requiring addition of the third drug (Pak‐Leung Ho et al. 9 ; Petrini 10 ). Hence, in our case, the patient was immunosuppressed; hence, we started on three drugs combination to prevent relapse and dissemination of disease. Also, though the patient responded completely in 2 months of treatment against M. marinum, we continued the treatment for up to 8 months to avoid recurrence.
Different case reports of spototrichoid M. marinum infection reported so far are summarized in Table 2.
TABLE 2.
Different case reports of sporotrichoid Mycobacterium marinum infection
| Author | No. of case | Patient status | Clinical presentation | Diagnosis | Treatment | Duration of treatment | Treatment Response | Follow‐up period |
|---|---|---|---|---|---|---|---|---|
| Ljungberg et al. (1987) 11 | 2 | Immunocompetent | Sporotrichoid spread in upper extremity | Culture; biopsy |
Case 1: rifampicin + ethambutol + surgery Case 2: cotrimoxazole |
Case 1: 8 months Case 2: 4 weeks |
Case 1: completely heales in last month of therapy Case 2: resolution in weeks of treatment |
Case 1: 10 months Case 2: 12 months |
| Preya kullavanijaya, et al. (1993) 12 | 1 | – | Sporotrichoid pattern in Lt Upper extremity | Culture +ve, biopsy: suggestive, AFB −ve) | Antitubercular drugs (HRZES) | 4–5 months | Complete resolution with scars after 2–3 months of therapy | – |
| A. Feddersen (1996) 13 | 1 | 3 years old | Sporotrichoid nodules in right upper extremity | Culture, biopsy | Rifampin (1 × 300 mg) and clarithromycin (2 × 125 mg) [4–6]. Protionamid (62.5 mg–125 mg‐62.5 rag) | – | Regression after 3 weeks of treatment though incomplete | |
| Ryan et al. (1997) 14 | 5 | Immunocompetent | Sporotrichoid nodules | Biopsy: consistent, AFB −ve) | Minocycline | 2–3 months | Complete resolution | |
| Rebecca et al. (1997) 15 | 1 | 27 months old boy | Sporotrichoid nodules in face | Culture confirmed | Oral clarithromycin (30 mg/kg/day) and rifampin (10 mg/kg/day) | 5 months | Gradual resolution of the lesions with minimal residual scarfing | |
| Saadatmand et al. (1999) 16 | 1 | Immune competent | Sporotrichoid nodules in right upper extremity, bursitis | Biopsy, culture | Minocycline | 6 months | Responded in 2 months of therapy | |
| Bhatty (2000) 17 | 2 | Diabetic | Sporotrichoid | Culture |
(i) Ciprofloxacin 500 mg twice daily and rifampicin 600 mg twice daily (ii) oral doxycycline 100 mg once daily and ciprofloxacin 500 mg twice daily |
3 months and 2 months, respectively | Complete cure | – |
| Fernando Torres (2001) 18 | 1 |
Lung transplant patient under immunosuppressants, Fish tank exposure |
4 nodules in right hand and forearm |
Culture +ve, biopsy: AFB−ve |
ethambutol 800 mg/day, azithromycin 500 mg/day, and minocycline 100 mg | 12 months | Complete resolution | Till 6 months after therapy completion |
| Aubry et al. (2002) 2 | 16 | – | Sporotrichoid | Culture confirmed | Clarithromycin, ethambutol, cyclines, rifampicin alone or in combination | Avg: 3.5 months |
15➔complete cure 1➔ treatment failure |
– |
| Lewis et al. (2003) 19 | 7 | 1 diabetic | Sporotrichoid | Culture, tissue AFB, biopsy |
1: clarithromycin + rifampicin excisional bx 6: Clarithromycin + ethambutol |
2–4 months | Complete resolution | |
| Mirjam Belić (2006) 20 | 1 | Immunocompetent | Verrucous painless nodules in right upper extremity in sporotrichoid fashion | Culture | rifampicin, ethambutol, and clarithromycin | 6 months | Complete resolution with residual scars | |
| Streit (2006) 21 | 1 | On oral immunosuppressants | EN like lesions in right upper extremity | Culture; tissue AFB+ve) |
Ethambutol + clarithromycin 4 months Later doxycycline added due to recurrence |
4 months + few months | Dramatic improvement f/b recurrence of newer lesions | |
| Schwendiman et al. (2009) 5 | 1 |
Immunocompetent, Aquarium cleaner |
Subcutaneous nodules with sporotrichoid spread in rt. Hand and forearm | biopsy ‐acid‐fast bacilli +, Culture confirmed) | four months of doxycycline without resolution➔ 4 months of clarithromycin 500 mg twice daily and ethambutol 1200 mg daily | 4 months +4 months |
Monotherapy➔ no response Combination therapy➔complete resolution in 2 months of therapy |
– |
| Fleming et al. (2017) 8 | 1 |
Immunocompetent, Fish tank exposure present |
erythematous and ulcerative papulonodules, left index finger to his upper arm in a sporotrichoid pattern |
presumptive on Biopsy: dermal granulomatous inflammation with multinucleate giant cells, lymphocytes, histiocytes and plasma cells, AFB stain: negative |
doxycycline, 100 mg orally twice daily | 3 months | Excellent | – |
| Present case report (2022) | 1 |
On immunosuppressants, Fish handler |
Sporotrichoid pattern of erythematous tender nodules on left hand and forearm | Mycobacterium marinum (biopsy: suggestive, with AFB positive) | Ethambutol 800 mg od + Clarithromycin 500 mg bd + Doxycycline 100 mg bd | 8 months | Complete resolution with residual scar | 9 months |
4. CONCLUSION
Sporotrichoid lesions are caused by infectious and noninfectious diseases. A detailed clinical history (triggering factor, the epidemiological context, immune status of patient, progression and evolution of lesion) and a careful physical examination with the help of investigations like cultures, histopathology, and will allow the initiation of a specific therapy in the majority of patients. As, in our case, detailed history and relevant investigations led to the diagnosis and proper treatment with satisfactory and effective response in the patient.
AUTHOR CONTRIBUTIONS
DKK involved in manuscript preparation and literature search, RA involved in manuscript preparation and served as a correspondence author. SA involved in concept, manuscript editing, guidance, and final approval.
FUNDING INFORMATION
None.
CONFLICT OF INTEREST
The authors have no conflicts of interest.
CONSENT
A written consent was obtained from the patient for the publication of the case and images.
ACKNOWLEDGMENTS
There are no acknowledgements for this case report.
Khadka DK, Acharya R, Agrawal S. Sporotrichoid lymphocutaneous pattern in a fish‐merchant under immunosuppressant medications: Clues to differential diagnoses. Clin Case Rep. 2022;10:e06708. doi: 10.1002/ccr3.6708
DATA AVAILABILITY STATEMENT
We agree to make the manuscript available to general people and are also ready to provide other necessary data regarding the manuscript in case required.
REFERENCES
- 1. Tirado‐Sánchez A, Bonifaz A. Nodular lymphangitis (Sporotrichoid lymphocutaneous infections). Clues to differential diagnosis. J Fungi. 2018;4(2):56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Aubry A, Chosidow O, Caumes E, Robert J, Cambau E. Sixty‐three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Arch Intern Med. 2002;162(15):1746‐1752. [DOI] [PubMed] [Google Scholar]
- 3. Rallis E, Koumantaki‐Mathioudaki E. Treatment of Mycobacterium marinum cutaneous infections. Expert Opin Pharmacother. 2007;8(17):2965‐2978. [DOI] [PubMed] [Google Scholar]
- 4. Ben M, Saghrouni F, Saadi‐Ben Y, et al. Sporotrichoid cutaneous Leishmaniasis in Central Tunisia: epidemiological and clinical aspects. Leishmaniasis – Trends in Epidemiology, Diagnosis and Treatment. IntechOpen; 2014. [Google Scholar]
- 5. Schwendiman MN, Johnson RP, Henning JS. Subcutaneous nodules with sporotrichoid spread. Dermatol Online J. 2009;15(5):9‐12. [PubMed] [Google Scholar]
- 6. Abudu B, Cohen PR. Sporotrichoid Keratoacanthomas: case report and review of neoplasms presenting in a Sporotrichoid pattern. Cureus. 2018;10:e3196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Krooks J, Weatherall A, Markowitz S. Complete resolution of Mycobacterium marinum infection with clarithromycin and ethambutol: a case report and a review of the literature. J Clin Aesthet Dermatol. 2018;11(12):48‐51. [PMC free article] [PubMed] [Google Scholar]
- 8. Fleming P, Keystone JS. Mycobacterium marinum infection with sporotrichoid spread from fish tank exposure. CMAJ. 2017;189(2):E76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Ho PL, Ho P, Fung BK, Ip WY, Wong SS. A case of disseminated Mycobacterium marinum infection following systemic steroid therapy. Scand J Infect Dis. 2001;33(3):232‐233. [DOI] [PubMed] [Google Scholar]
- 10. Petrini B. Mycobacterium marinum: ubiquitous agent of waterborne granulomatous skin infections. Eur J Clin Microbiol Infectious Dis. 2006;25(10):609‐613. [DOI] [PubMed] [Google Scholar]
- 11. Ljungberg B, Christensson B, Grubb R. Failure of doxycycline treatment in aquarium‐associated Mycobacterium marinum infections. Scand J Infect Dis. 1987;19(5):539‐543. [DOI] [PubMed] [Google Scholar]
- 12. Kullavanijaya P, Sirimachan S, Bhuddhavudhikrai P. Mycobacterium marinum cutaneous infections acquired from occupations and hobbies. Int J Dermatol. 1993;32(7):504‐507. [DOI] [PubMed] [Google Scholar]
- 13. Feddersen A, Kunkel J, Jonas D, Bhakdi S, Husmann M, Engel V. Infection of the upper extremity by Mycobacterium marinum in a 3‐year‐old boy—diagnosis by 16 S‐rDNA analysis. Infection. 1996;24(1):47‐48. [DOI] [PubMed] [Google Scholar]
- 14. Ryan JM, Bryant GD. Fish tank granuloma – a frequently misdiagnosed infection of the upper limb. Emerg Med J. 1997;14(6):398‐400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Brady RC, Sheth A, Mayer T, Goderwis D, Schleiss MR. Facial sporotrichoid infection with Mycobacterium marinum . J Pediatr. 1997;130(2):324‐326. [DOI] [PubMed] [Google Scholar]
- 16. Saadatmand B, Poulton JK, Kauffman CL. Mycobacterium marinum with associated bursitis. J Cutan Med Surg. 1999;3(4):218‐220. [DOI] [PubMed] [Google Scholar]
- 17. Bhatty MA, Turner DP, Chamberlain ST. Mycobacterium marinum hand infection: case reports and review of literature. Br J Plast Surg. 2000;53(2):161‐165. [DOI] [PubMed] [Google Scholar]
- 18. Torres F, Hodges T, Zamora MR. Mycobacterium marinum infection in a lung transplant recipient. J Heart Lung Transplant. 2001;20(4):486‐489. [DOI] [PubMed] [Google Scholar]
- 19. Lewis FM, Marsh BJ, von Reyn CF. Fish tank exposure and cutaneous infections due to Mycobacterium marinum: tuberculin skin testing, treatment, and prevention. Clin Infect Dis. 2003;37(3):390‐397. [DOI] [PubMed] [Google Scholar]
- 20. Belic M, Miljkovic J, Marko PB. Sporotrichoid presentation of Mycobacterium marinum infection of the upper extremity. A case report. Acta Dermatovenerol Alp Pannonica Adriat. 2006;15(3):135. [PubMed] [Google Scholar]
- 21. Streit M, Lm B, Hunziker T, et al. Disseminated Mycobacterium marinum infection with extensive cutaneous eruption and bacteremia in an immunocompromised patient. Eur J Dermatol. 2006;16(1):79‐83. [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
We agree to make the manuscript available to general people and are also ready to provide other necessary data regarding the manuscript in case required.
